Results 81 to 90 of about 626,622 (390)

American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Blood Advances, 2019
BACKGROUND Venous thromboembolism (VTE) is a common source of perioperative morbidity and mortality. OBJECTIVE These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about preventing VTE in ...
D. Anderson, G. P. Morgano, Carole Bennett, F. Dentali, C. Francis, D. Garcia, S. Kahn, Maryam Rahman, A. Rajasekhar, F. Rogers, M. Smythe, K. Tikkinen, A. Yates, Tejan Baldeh, S. Balduzzi, J. Brożek, I. Ikobaltzeta, H. Johal, I. Neumann, W. Wiercioch, J. Yepes-Nuñez, H. Schünemann, P. Dahm   +22 more
semanticscholar   +1 more source

Venous Thromboembolism Risk With JAK Inhibitors: A Meta‐Analysis

Arthritis & Rheumatology, 2020
JAK inhibitor therapies are effective treatment options for immune‐mediated inflammatory diseases (IMIDs), but their use has been limited by venous thromboembolism (VTE) risk warnings from licensing authorities.
M. Yates, Amanda Mootoo, M. Adas, K. Bechman, S. Rampes, Vishit Patel, S. Qureshi, A. Cope, S. Norton, J. Galloway   +9 more
semanticscholar   +1 more source

Impact of Combined Resection of the Pancreas on Long‐Term Survival in Gastric Cancer

Annals of Gastroenterological Surgery, EarlyView.
Short‐term and long‐term results of patients underwent conbined pancreatectomy was investigated in 64 patients with gastric cancer. R1 resection and postoperative intraabdominal infectious complications were identified as independent prognostic factors.
Taku Hattori, Masanori Terashima, Yusuke Koseki, Kenichiro Furukawa, Keiichi Fujiya, Yutaka Tanizawa, Katsuhisa Ohgi, Teiichi Sugiura, Etsuro Bando   +8 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source

Minor injuries as a risk factor for venous thrombosis [PDF]

, 2008
BACKGROUND: Injuries increase the risk of venous thrombosis. So far, most research has focused on major injuries that are accompanied by other risk factors for venous thrombosis, such as plaster casts and surgery.
Doggen, Carine J.M., Rosendaal, Frits R., Stralen, Karlijn J. van   +2 more
core   +3 more sources

Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. [PDF]

PLoS ONE, 2014
BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease.
Hilde Jensvoll, Kristine Blix, Sigrid K Brækkan, John-Bjarne Hansen   +3 more
doaj   +1 more source

Cytokine and chemokine regulation of venous thromboembolism

Journal of Thrombosis and Haemostasis, 2020
Morbidity and mortality from venous thromboembolism (VTE), which refers to deep vein thrombosis and pulmonary embolism, have a substantial effect on the global burden of disease.
Mariame Najem, F. Couturaud, C. Lemarié
semanticscholar   +1 more source

Facts and Misfacts on D‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET)

American Journal of Hematology, EarlyView.
ABSTRACT D‐dimer defines degradation products derived from the proteolysis mediated by plasmin on cross‐linked fibrin. The evidence‐based use of D‐dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D‐dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start
Armando Tripodi, Walter Ageno, Luca Barcella, Antonio Coppola, Marcello Di Nisio, Massimo Franchini, Monia Marchetti, Rossella Marcucci, Marco Marietta, Pasquale Pignatelli, Domenico Prisco, Valerio De Stefano   +11 more
wiley   +1 more source

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]

, 2002
Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley, Anderson, Bloemenkamp, Daly, E. Daly, F. M. Helmerhorst, F. R. Rosendaal, G. D. O. Lowe, Grady, Grodstein, Hulley, Jick, Kniffin, Lowe, M. Vessey, M. Woodward, Mehta, Nordström, Oger, Rees, Rosendaal, Rosendaal, Silverstein, Stadel, Vandenbroucke, Vessey, Woolf   +26 more
core   +1 more source

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

Haematologica, 2016
Venous thromboembolism occurs frequently in cancer patients. Two variants in the factor 5 gene (F5), rs6025 encoding for the factor V Leiden mutation R506Q, and rs4524 encoding K858R, have been found to be associated with venous thromboembolism.
Olga V. Gran, Erin N. Smith, Sigrid K. Brækkan, Hilde Jensvoll, Terry Solomon, Kristian Hindberg, Tom Wilsgaard, Frits R. Rosendaal, Kelly A. Frazer, John-Bjarne Hansen   +9 more
doaj   +1 more source